The present document describes a screening composition comprising a marker compound, chosen from at least one of iodine, and fluorescein; eosin Y, erythrosine, ponceau S, calcein, a catalyst, chosen from at least one boron trioxide (B2O3), potassium (K), Gallium (III) oxide (Ga2O3), Nickel (II) oxide (NiO), Vanadium (V) oxide (V2O5), magnesium oxide (MgO), a bismuth oxide chosen from bismuth subcarbonate [Bi2O2(CO3)], bismuth chloride oxide (BiClO), and bismuth oxide (Bi2O3), cesium bromide (CsBr), lanthanum (III) oxide (La2O3), molybdenum (VI) oxide (MoO3), neodymium oxide (Nd2O3), Nickel (II) carbonate anhydrous (NiCO3); and a pigment, chosen from at least one of scandium (III) oxide (Sc2O3), Lead (IV) oxide (PbO2), Sulfur (S) powder, and Tungsten (VI) oxide (WO3), chromium (III) oxide (Cr2O3), copper (II) oxide (CuO), copper (I) oxide (Cu2O), iron (III) oxide (Fe2O3), lead (II) oxide (PbO). The document also describes method of using the same.